These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9346366)

  • 21. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The yin and yang of rheumatoid arthritis.
    Birmingham K
    J Clin Invest; 2003 Oct; 112(8):1126. PubMed ID: 14561693
    [No Abstract]   [Full Text] [Related]  

  • 23. New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis.
    Breedveld F
    Eur Cytokine Netw; 1998 Sep; 9(3):233-8. PubMed ID: 9831171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
    Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
    Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
    Roberts-Thomson PJ; Smith MD; Ahern MJ
    Arthritis Rheum; 1998 Mar; 41(3):564-5. PubMed ID: 9506588
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
    Ulfgren AK; Andersson U; Engström M; Klareskog L; Maini RN; Taylor PC
    Arthritis Rheum; 2000 Nov; 43(11):2391-6. PubMed ID: 11083259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
    Netea MG; Radstake T; Joosten LA; van der Meer JW; Barrera P; Kullberg BJ
    Arthritis Rheum; 2003 Jul; 48(7):1853-7. PubMed ID: 12847679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis.
    di Comite G; Marinosci A; Di Matteo P; Manfredi A; Rovere-Querini P; Baldissera E; Aiello P; Corti A; Sabbadini MG
    Ann N Y Acad Sci; 2006 Jun; 1069():428-37. PubMed ID: 16855170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
    Szekanecz Z; Szegedi G
    Orv Hetil; 1998 Apr; 139(14):819-23. PubMed ID: 9569729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
    Sugiyama E
    Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages and their products in rheumatoid arthritis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
    Feldmann M; Brennan FM; Williams RO; Woody JN; Maini RN
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):59-80. PubMed ID: 15123038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
    Robinson WH; Genovese MC; Moreland LW
    Arthritis Rheum; 2001 Sep; 44(9):1977-83. PubMed ID: 11592357
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of rheumatoid arthritis with cytokine antagonists].
    Manger B
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):101-4. PubMed ID: 10355058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of severe rheumatoid arthritis.
    Lorenzen I
    Ann Clin Res; 1983 Apr; 15(2):80-7. PubMed ID: 6349514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of inflammatory mediators with premature atherosclerosis in rheumatoid arthritis and healthy controls: comment on the article by Rho et al.
    Welsh P; Sattar N; Peters M
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1052-3; author reply 1053-4. PubMed ID: 20589689
    [No Abstract]   [Full Text] [Related]  

  • 40. [The mechanism of the action of laser therapy in rheumatoid arthritis].
    Kozlova IS; Tsurko VV; Piriazeva NA; Volkova ZI; Kariakina EV; Nikolaev VI; Mul'diiarov PIa
    Ter Arkh; 1994; 66(5):38-41. PubMed ID: 7940336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.